Skip to content

Samantree Medical

Active
Public limited companyfounded 2024active for 2 yearsRue de Bruxelles 174, 4340 Awans, Belgium38 active companies are registered at this addressKBO/BCE: BE 1010.646.067

From the official registers: KBO 1 annual account at the National Bank publications in the Belgian Official Gazette

Summary

Samantree Medical has been active since 2024 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €39.1m and a net result of -€5.1m. Its solvency ranks better than 73% of 172 sector peers (NACE 26, financial year 2025). The computed 12-month bankruptcy probability is 0.2% (very low).

Risk analysisFollow ReportCompare
Samantree MedicalActiveChecked score 89/100
Risk analysis ReportCompare

Overview

Official details

KBO
Status
Active since 23-06-2024 Normal situation
Legal form
Public limited company
Registered office
Rue de Bruxelles 174, 4340 Awans
Activity
Manufacture of computer, electronic and optical products NACE 26600
Establishment unit
2.361.722.346 4340 Awans, since 23-06-2024
Financial year end
31 December
Peppol
Reachable since 10-12-2025
Company details

Who decides

Board
and 2 other directors
Auditor
PricewaterhouseCoopers Reviseurs d'Entreprises
Holdings
Shares in 4 companies including SamanTree Medical (Switzerland) SA and SamanTree Medical France
Board & ownership

How it is doing

89 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
0.2%
Annual accounts 2025
Gross margin
-€3.5m
Loss
€5.1m
Equity
€39.1m
Total assets
€53.9m
Staff
5.2 FTE
2025 accounts 17 days early
Filed on 14-07-2026PDF
Financials
Why 89raises riskLoss of €5.1m (financial year 2025)lowers riskSector: Manufacture of computer, electronic and optical products (NACE 26)Size: 5.2 FTE, total assets €53.9mEquity €39.1m (72.4% of total assets)Show the evidence

Checked score

Score 2025
89 / 100
Excellent
Probability in this band: under 0.55%
Financially better than 49% of its sector peers (NACE 26, micro)
Every signal that counts is listed under Signals.
Financial strength
Average
Solvency 97
equity 72.4% of total assets
Liquidity 56
short-term debt 14.4% · cash 7.3%
Profitability 7
return on assets -9.5%
Bankruptcy probability, 12 months
0.2% Very low
0%0.5%1.5%4%10%≥ 25%

About 2 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median 0.1% (447 companies, NACE 26, micro)
Last 24 months 07-2025: 0.8% 08-2025: 0.8%● unchanged vs 07-2025 09-2025: 0.8%● unchanged vs 08-2025 10-2025: 0.8%● unchanged vs 09-2025 11-2025: 0.8%● unchanged vs 10-2025 12-2025: 0.9%▲ +0.1 percentage points vs 11-2025 01-2026: 0.9%● unchanged vs 12-2025 02-2026: 1.0%▲ +0.1 percentage points vs 01-2026 03-2026: 1.0%● unchanged vs 02-2026 04-2026: 1.0%● unchanged vs 03-2026 05-2026: 1.1%▲ +0.1 percentage points vs 04-2026 06-2026: 1.1%● unchanged vs 05-2026highest value 07-2026: 1.1%● unchanged vs 06-2026highest value 08-2026: 0.5%▼ -0.6 percentage points vs 07-2026 09-2026: 0.5%● unchanged vs 08-2026 10-2026: 0.2%▼ -0.3 percentage points vs 09-2026lowest value
Credit of up to €3,450,000 on 30-day terms, only on tighter conditions: young company (under 3 years) without a track record
Liquidity ample (current ratio 2.76, above the usual 1.5; short-term debt: 14.4% and cash: 7.3% of total assets), and 27.6% of the assets are financed with debt and provisions.
How it is calculated

The band follows from the bankruptcy probability, on a scale where 10 more points roughly halve it:

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 26, micro): better than 73% on solvency, 51% on liquidity and 23% on profitability.

The bankruptcy probability was computed on 31-10-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. Negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late hold it at Fair at most (59); two missing filings, at Weak (44). An ongoing judicial reorganisation or the company's end (bankruptcy, dissolution, liquidation) holds it at Critical at most (24).

Credit check for your own amount and term

Show the recommended maximum and see how the verdict changes with amount, term and advance.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Manufacture of computer, electronic and optical products (NACE 26)
KBO
raises risk · Loss of €5.1m (financial year 2025)
NBB · annual accounts
lowers risk · Size: 5.2 FTE, total assets €53.9m
Companies of this size fail less often; how much that weighs depends on the rest of its profile.
NBB · annual accounts
lowers risk · Equity €39.1m (72.4% of total assets)
NBB · annual accounts
raises risk · Young company
Founded in 2024, 2 years ago. Young companies fail more often than established ones; the risk is highest 2 to 8 years after founding.
KBO · incorporation date
Age against the risk zone
highest failure risk from 2 to 8 years 2 years 0 10 years
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 14-07-2026, 17 days ahead of the deadline.
NBB · 1 filing
Deviation from the deadline
2025
17 days early
← before the deadline after the deadline →
Searched, nothing found (1)
neutral · No strike-offs in the KBO publications
Searched since incorporation in 2024.
KBO publications · our coverage

Key points

  • Caution: Among the weakest 9% on net resultsector median €109,628 · 173 companies -€5.1m View
  • Heads a groupcompanies controlled 4 View

Documents

Annual accounts at the NBB

Acts in the Belgian Official Gazette

All publications in the Belgian Official Gazette

Articles and registers

Key facts about Samantree Medical

What is the company number of Samantree Medical?
1010.646.067. In Belgium the VAT number is the company number with BE in front: BE 1010.646.067.
Where is Samantree Medical based?
The registered office is at Rue de Bruxelles 174, 4340 Awans.Company details
What does Samantree Medical do?
According to the KBO register, the main activity is manufacture of computer, electronic and optical products (NACE 26600).
What is the legal form of Samantree Medical?
Public limited company (NV).
When was Samantree Medical founded?
On 23-06-2024.
Is Samantree Medical still active?
Yes, Samantree Medical is an active enterprise in the KBO register.
How many employees does Samantree Medical have?
On average 5.2 full-time equivalents in financial year 2025, according to the filed annual accounts.Financials
What is the turnover of Samantree Medical?
The annual accounts for financial year 2025 state no turnover.
Is Samantree Medical profitable?
In financial year 2025, Samantree Medical made a loss of €5.1m.
Where can I find the annual accounts of Samantree Medical?
Samantree Medical filed 1 annual account with the National Bank of Belgium, for financial year 2025.Annual accounts 2025 (PDF)

Companies related to Samantree Medical

Go further with this company

How much credit can you give this customer, and on what payment terms?Credit check What should you check before you do business with this company?Supplier due diligence Can you accept this company as a client under the anti-money-laundering law?AML client file Which of your other customers can you e-invoice via Peppol?Peppol check How does this company compare with its sector?Sector benchmark Is the workforce growing, and do people stay?Employer check

Your own company? See how customers, suppliers and banks see it and what to improve first.

Investigating this company? Keep it with today's facts in a case file.

We would like to set cookies. That happens only with your consent. What we measure